Published in Cancer Weekly, February 2nd, 2010
"Patients were allocated to receive either a placebo (group A, n=10), or a dose of 10(7) of a mixture of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.